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The Smoothened (Smo) signalling pathway participates in many developmental processes, contributing to the regulation of gene expression by
controlling the activity of transcription factors belonging to the Gli family. The key elements of the pathway were identified by means of genetic
screens carried out in Drosophila, and subsequent analysis in other model organisms revealed a high degree of conservation in both the proteins
involved and in their molecular interactions. Recent analysis of the pathway, using a combination of biochemical and cell biological approaches, is
uncovering the intricacies of Smo signalling, placing its elements in particular cellular compartments and qualifying the molecular processes
involved. These include the synthesis, secretion and diffusion of the ligand, the activation of the receptor and the modifications in the activity of
nuclear effectors. In this review we discuss recent advances in understanding biochemical and cellular aspects of Smo signalling, with particular
focus in the similarities in the mechanism of signal transduction between Smo and other transmembrane proteins belonging to the G-Protein
coupled receptors superfamily (GPCR).
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development and disease
The components of the Smo signalling pathway were
identified by their similar requirements during embryonic
segmentation and appendage development in Drosophila
[1,2]. Since then, the number and variety of developmental
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both in Drosophila and vertebrates [3–7]. Most often Smo
functions during embryonic development, in processes such as
digit patterning in the chick limb bud and left–right asymmetry
of vertebrate embryos. In addition, Smo function is also
fundamental for the maintenance of tissue homeostasis in adults,
and deregulated Smo signalling is implicated in tumorogenesis.
Most of the elements of the Smo pathway have been identified
through genetic screenings carried out in Drosophila and, more
recently, by the use of systematic searches in cell culture
experiments [8,9]. Simultaneously, the use of biochemical
approaches has unravelled many of the complexities of the
pathway, allowing a partial understanding of the molecular
interactions that translate the binding of the ligand Hedgehog
(Hh) to its receptor Patched (Ptc) into the functional state of the
transcription factor Cubitus interruptus (Ci), and hence to the
regulation of gene expression in response to Hh [10].
Most of the elements of the pathway are conserved from flies
to vertebrates, the main difference being the number of related
genes present in different organisms [7]. Thus, there is only oneTable 1
Elements of the Smo signalling pathway in flies and vertebrates
Drosophila
Ligands Hedgehog (Hh)
Processing and transport of ligand Rasp (Rasp)
Dispatched (Disp)
Dally and Dally-like (Dlp)
Tout-velu (Ttv)
Sister of tout-velu (Sotv)
Brother of tout-velu (Botv)
Shifted (Shf)
Receptors Patched (Ptc)
Co-receptors Interference Hedgehog (Ihog)
Brother of Ihog (Boi)
Transducter Smoothened (Smo)
Other Hh-binding factors Pxb
Cytoplasmic regulators Costal2 (Cos)
Fused (Fu)
Suppressor of Fused (Su(Fu))
Smo and/or Ci regulators PKA
Casein Kinase I (CKI)
Glycogen synthase kinase 3 (GSK3)
?
Slimb
Gprk2
Transcription factors Cubitus interruptus (Ci)
References are indicated in the text, and can be found in the following reviews: [3–Hh gene in flies and three Hh-related genes in vertebrates, so-
nic-hedgehog, desert-hedgehog and indian-hedghog, which are
expressed in different tissues and stages of development [11].
Similarly, there is only one gene encoding the receptor Ptc in
Drosophila and two Ptc proteins (PTC1 and PTC2) in
vertebrates (Table 1). The main effectors of Smo signalling,
the Gli proteins related to Drosophila Ci, are also conserved in
vertebrates, where at least three Gli proteins are found (GLI1,
GLI2 and GLI3). In the mouse, these proteins mediate all Hh-
dependent patterning in the neural tube [12,13]. Like Ci, all
three vertebrate Gli proteins have five highly conserved zinc
finger DNA binding domains and C-terminal activation
domains, with Gli2 and Gli3 also having N-terminal repressor
domains [12,14]. Truncations, point mutations, and frame shifts
changes in human Gli3 lead to a variety of diseases including
Greig cephalopolysyndactyly syndrome (GCPS) [15–17],
Pallister–Hall syndrome (PHS) [18], and postaxial polydactyly
type A (PAP-A) [19].
Despite the conservation in the components of Smo pathway
during evolution, some caveats remain as to the preservation ofVertebrates Main features
Sonic Hedgehog (SHH) Secreted signalling protein
Desert Hedgehog (DHH)
Indian Hedgehog (IHH)
Skinny Hh (SKN) Acyl transferase
Dispatched A (DISPA) Sterol-sensing domain protein
? Glypicans
Exotosin (EXT) HSPGs biosynthesis
Secreted protein
Patched 1 (PTC1) 12-TM protein
Patched 2 (PTC2)
CDO Fibronectin type III and Ig domains
trans-membrane proteinBOC
Megalin LDL superfamily protein
Smoothened (SMO) 7-TM protein
Hh-interacting Protein (HIP) 1-TM protein
KIF7 Kinesin family member
KIF3a
IFT88 Intraflagellar transport protein
IFT172
Fused (FU) S/T kinase
Suppressor of Fused (SUFU) Negative regulator
Missing in metastasis (MIM) Positive regulator
Iguana Positive regulator
FKBP8 Negative regulator
SIL Negative regulator
Rab23 Negative regulator
PKA S/T Kinase
CKI S/T Kinase
GSK3 S/T Kinase
β-arrestin-2 GPCR binding protein
{beta}TrCP F-box/WD40
GRK2 GPCR kinase
GLI1 Zn-finger transcription factor
GLI2
GLI3
7,10,11,20,22,42–45,90] and for Gprk2 in flies [132].
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[20]. Particularly perplexing has been the difficulties in relating
the mechanisms of Smo signal transduction to that of other
transmembrane proteins with a similar molecular structure, the
G-protein coupled receptor (GPCR) superfamily of seven
transmembrane domains proteins.
In this review we will summarize recent advances in the
identification of the molecular mechanisms involved in Smo
signal transduction, emphasizing the relationships between Smo
and other GPCRs, and the participation in Smo signalling of
several components of classic GPCR pathways, such as
heterotrimeric G-proteins, β-arrestins and G-protein coupled
receptor kinases (GRKs).
2. The elements of the Smo signalling pathway and the
mechanisms of Smo signal transduction
The core members of the Smo signalling pathway include the
ligand (Hedgehog, Hh), the receptor (Patched, Ptc), severalFig. 1. The Hedgehog signalling network. (i) Right panel, signalling cell (C): Hh auto
Cholesterol-modified Hh can be palmitoylated at its N-terminal, a reaction that is
processed at the plasma membrane, where it multimerizes. Multimeric Hh secretion r
Left panel (A), non-responding cells: In the absence of Hh, Ptc inhibits Smo acti
degradation. Ci, the downstream transcription factor of the Hh pathway, is silenced b
protein is part of a microtubule-bound multimeric complex involving Cos2, Fu and d
ubiquitination by Slimb to generate the truncated transcriptional repressor (Ci75), and
binds target genes and blocks their transcription. The other Ci pool in the cell appears
retention of Ci. (iii) Central panel (B), Hh-responding cells. When Hh binds to P
downstream components. The putative co-receptors Megalin, Ihog and Boi are repr
complex, causing hyperphosphorylation of Cos2 and Fu and their subsequent release
Ci155 can then travel to the nucleus and function as a transcriptional activator. Smo ac
length Ci155 from Su(fu) and its nuclear localisation.transducers such as Smoothened (Smo) and the cytoplasmic
complex formed by the kinesin-like protein Costal-2 (Cos2), the
serine/threonine kinase Fused (Fu), the novel protein Suppres-
sor of fused [Su(fu)], and the transcription factor Cubitus
interruptus (Ci) [7,21]. In addition, several proteins participate
in the correct secretion and movement of active Hh, in the
phosphorylation of Ci and Cos2, and in the processing and
degradation of Ci [21,22]. In this manner, the Smo pathway can
be sub-divided into several “molecular modules” participating
in (i) the formation, secretion and movement of active Hh, (ii)
the intracellular trafficking, sorting and recycling of Hh/Ptc/
Smo complexes, (iii) the relay complex formed by Cos2, Fu, Ci
and in some instances Su(fu), and (iv) the enzymatic machinery
that by phosphorylation (GSK3, CKI and PKA) or proteolysis
(Slimb) modulates the activities of Smo, Cos2, Fu and Ci (Table
1 and Fig. 1).
The final outcome of Smo signalling consists in modifica-
tions to the stability, phosphorylation and subcellular
localisation of the transcription factor Ci/Gli, in a process-processing generates an N-terminal domain with a C-terminal cholesterol motif.
catalysed by the acyl-transferase Sightless. Lipid-modified Hh can be further
equires the function of Disp, making Hh available for long-range signalling. (ii)
vity. Ptc acts by directing Smo to endocytic vesicles, where it is targeted for
y protein-interactions that take place in two different complexes: most of the Ci
ifferent kinases (as PKA, CKI and GSK3β) that phosphorylate Ci, promoting its
its degradation by the proteasome in a process dependent on Debra activity. Ci75
as complexes between full-length Ci155 and Su(fu), resulting in the cytoplasmic
tc, releases the repression that Ptc exerts on Smo, allowing the activation of
esented to the left of Ptc. Smo is phosphorylated and signals to the Cos2/Fu/Ci
from the microtubules. Fu itself participates in Cos2 phosphorylation. Stabilized
tivation also allows Su(fu) phosphorylation by Fu, promoting the release of full
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transition of Ci from the “inactive” state (repressor form),
defined by the presence in the nucleus of the processed form
Ci-75 and the cytoplasmic accumulation of Ci (Fig. 1A), to
the “active” state (activator form), characterised by the
presence in the nucleus of full-length Ci-155 and the absence
of Ci-75, is triggered by interaction between the receptor Ptc
and the ligands of the Hedgehog (Hh) family (Fig. 1B). These
ligands are secreted proteins synthesized as precursors
containing a signal peptide, and possess auto-proteolytic
activity [7] (Fig. 1C). In addition, after its synthesis and
before their apical secretion to the extracellular space, Hh
proteins are modified by the addition of lipid molecules [22].
Thus, Hh is cleaved within the secretory pathway in an
autoproteolytic reaction and a cholesterol molecule is
incorporated in its C terminus of the N-terminal fragment,
giving rise to the Hh-Np active form [22]. A second lipid
modification is the addition of palmitic acid to the N terminus
of Hh-Np, in a reaction catalysed by the acyl transferase Rasp
[23,24]. The analysis of mutated forms of Hh in flies suggests
that absence of cholesterol-modification in Hh-Np affects its
secretion, multimerization and long-range signalling activity
[25,26], as was previously recognized in mammalian systems
[27–29]. Similarly, the lack of acylation reduces dramatically
Hh signalling, both in Drosophila and vertebrates.
Once Hh is modified by lipids, it must be secreted to the
extracellular space. It has been shown that the protein encoded
by the gene dispatched (disp) is required to liberate lipid-
modified Hh from Hh producing-cells [27,30]. Thus, disp
mutant cells retain lipid-modified Hh, whereas unmodified Hh-
N is secreted independently of Disp function. Disp contains,
like Ptc, twelve transmembrane domains and a sterol-sensing
domain (SSD), which has been involved in cholesterol home-
ostasis and cholesterol-linked signalling [22].
Hh interacts with the twelve-pass transmembrane receptor
Patched (Ptc) of neighbouring cells, and the range of Hh
diffusion and effectiveness varies in different developmental
systems [31–35]. Extracellular matrix proteins such as heparan
sulfate proteoglycans (HSPGs) participate in the movements of
Hh once it has been secreted, and might contribute to the
presentation of Hh to its receptor Ptc. Thus, the Drosophila
EXT family of proteins encoded by the genes tout velu (ttv),
brother of tout velu (botv) and sister of tout velu (sotv) are
essential for the synthesis of HSPGs and are required for the
diffusion of lipid-modified Hh [36,37]. The proteins Dally and
Dally-like (Dlp) are glypicans forming the HSPGs core, and are
also required for Hh diffusion [38,39]. Another protein recently
implicated in the spreading of Hh is a secreted protein encoded
by the gene shifted (shf), that is required for normal
accumulation of Hh in the extracellular matrix of Hh-producing
cells and for lipid-modified Hh diffusion [40,41]. Shf is the
ortholog of the human Wnt inhibitory factor (WIF), a secreted
antagonist of the Wingless pathway. However, Shf has not effect
on Wingless activity in Drosophila. Finally Megalin, a multi-
domain transmembrane protein [42] and a novel and evolutio-
narily conserved family of transmembrane proteins containing
Ig domains and two extracellular fibronectin type III domains,Ihog and Boi in flies and CDO and BOC in mammalians, bind
to Hh, and might function as co-receptors in Hh reception [43–
45].
The interaction between Hh and Ptc releases the repression
that Ptc exerts on Smo, allowing the activation of downstream
components. The mechanism of Smo activation includes the
internalisation of Hh/Ptc/Smo complexes from the cell mem-
brane, the sorting of Hh/Ptc from Smo in endocytic vesicles, the
phosphorylation of Smo by several Ser/Thr kinases including
CKI and PKA and the accumulation of phosphorylated Smo in
basolateral cell membranes [10,21] (Fig. 1B). The intracellular
trafficking of Ptc and Smo through the late endosome–lysosome
system is thought to be critical for the regulation of Smo activity
by Ptc [46], although the analysis of a Drosophila mutant Ptc
protein defective in Hh internalisation suggests that Hh
internalisation and Smo signalling can be uncoupled [47]. It
has been suggested that Ptc, in the absence of Hh and acting in a
similar manner to other proteins containing Sterol-sensing
domains, directs Smo to a cellular compartment where it is
targeted for degradation [48–50]. The exposure of cells
expressing Ptc and Smo to Shh leads to the co-internalisation
of Ptc, Smo and Shh, and to the degradation of Ptc and Shh in
lysosomes [51]. Thus, after entering late endosomes together,
Smo is segregated from the Ptc–Shh complex, and returns to the
cell surface, where it is now ready to signal [51]. Interestingly,
constitutively active mutant Smo proteins that are not inhibited
by Ptc (isolated from sporadic basal cell carcinomas), fail to co-
localise and co-internalise with Ptc, allowing the activation of
the pathway independently of Hh [50].
Once activated, the interactions between Smo and the
cytoplasmic complex formed by Cos2, Fu, Su(fu) and Ci
changes in a way that the processing and degradation of Ci stops,
allowing the accumulation of full-length Ci and its entrance into
the nucleus, where it can bind DNA and regulate the expression
of its target genes [7,21]. Hh does not alter Smo–Cos2 affinity,
but it does increase the total amount of Smo–Cos2 complex and
alter its location. Thus, in the absence of Hh, or when Ptc is
present in excess, Smo is localised in cytoplasmic vesicles, and
Cos2 scaffolds multiple kinases, increasing the accessibility of
Ci to these kinases and facilitating extensive phosphorylation of
Ci by PKA, CKI and GSK3, targeting Ci for proteolytic
processing mediated by the ubiquitin ligase Slimb ([52]; Fig.
1A). Dbr enhances poly-ubiquitination of Ci, promoting its
degradation [53] (Fig. 1A). In this manner Ci is either degraded
by the proteosome, or converted into a 75 Kd form (Ci-75) that
enters the nucleus and represses the transcription of target genes
(Fig. 1A). In the presence of Hh, or when Ptc is absent, Cos2
complexes are recruited to the cell surface via Smo, and its
components Cos2, Fu and Su(fu) become phosphorylated by the
Fu kinase, among others [54] (Fig. 1B). This leads to the
disassembly of Cos2-Ci-kinase complexes. As a consequence,
Ci phosphorylation is compromised and Ci processing does not
take place, allowing the accumulation of the full-length form of
Ci (Ci-155) in the cytoplasm and its entrance into the nucleus
[55–60]. A significant fraction of Su(fu) associates with Ci,
whereas a smaller fraction may also associate with Cos2 and Fu,
in at least two distinct complexes, one comprising Ci/Su(fu) and
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key role in the transition from Ci-75 to Ci-155 through
interactions with Smo. Early studies of Cos2 identified a
negative role for Cos2 in pathway regulation, because cos2
mutations caused inappropriate activation of signalling [62,63].
This antagonism is due to the requirement of Cos2 for both
cytoplasmic retention of Ci and its proteolytic processing to
produce Ci-75 [64–66]. More recently, additional requirements
for Cos2 have been identified, including the stabilization of Fu
and the accumulation of activated Smo. The transition of Cos2
from a pathway suppressor to activator requires adequate levels
of activated Smo, and it has been proposed that Cos2 acts as a
scaffold and sensor that, by transducing pathway activation from
Smo to Ci, actively participates in the transition of Ci from the
inactive to the active state [60].
Although some details of the molecular interactions that
participate in Ci modifications are still lacking, it is clear that
Hh binding to Ptc triggers modifications in Smo that alter its
stability and subcellular localisation, shifting the Cos2/Fu/Su
(fu) complex from a state that promotes the formation of Ci-75
to another state in which the accumulation of Ci-155 is
favoured, leading to changes in the expression of genes
containing Ci-binding sequences (Fig. 1B). In what follows,
we will consider the similarities between Smo and other
proteins of the GPCR superfamily, and discuss the possibility
of shared mechanisms regulating Smo and other GPCRs.
3. Smoothened as a member of the GPCR family
The super-family of G-protein coupled receptors (GPCRs) is
one of the largest families of proteins in vertebrates, with circa
1000 genes encoding for such receptors identified in the human
genome [67–69]. GPCRs participate in a variety of important
physiological functions and are targets for many drugs. The
ligands that activate GPCRs are molecularly diverse, and
include ions, organic odorants, amines, peptides, proteins,
lipids, and nucleotides. In addition many GPCRs have also been
denominated ‘orphan receptors’, because their natural ligands
have escaped identification so far [13]. The main structural
characteristic of the family is the seven membrane-spanning α-
helices (TMHs), which span the membrane in an anti-clockwise
manner and are formed by 25–35 consecutive amino acid
residues with some degree of hydrophobicity. These helices are
connected by extracellular and intracellular hydrophilic loops,
with an extracellular N-terminus and a cytoplasmic C-terminus.
Most GPCRs, as its name indicates, mediate their intracellular
actions through pathways involving interaction and activation
of heterotrimeric G-proteins, although G-protein-independent
signalling mechanisms have also been reported for some
GPCRs. In addition several non-GPCR receptors use hetero-
trimeric G-proteins and other cytoplasmic proteins related to
GPCR activity as transducers in their signalling. For these
reasons, some authors used alternative names for this protein
superfamily such as “7-transmembrane receptors”, “serpentine-
like receptors” or “heptahelical receptors” [70–72].
The Hh/Smo signalling pathway differs in several aspects
from the canonical mechanisms of 7-transmembre receptorsactivation. Smo lacks the ability to directly interact with the
secreted ligand, and uses Ptc as the receptor for Hh. In this
case, receptor activation involves the release of Smo from Ptc
inhibition, triggered by Hh/Ptc interactions, and the intracel-
lular sorting of activated Smo from Hh/Ptc complexes [51].
However, several features of the Smo pathway are related to
those of the GPCR superfamily and are discussed below,
including structure and membrane localisation, the possible
implication of dimerization in its mode of activation, and the
existence of post-transcriptional modifications and internalisa-
tion mechanisms from the cell membrane in the presence of
ligand.
3.1. Smoothened receptor structure and sequence similarity
All published classifications of GPCRs superfamily mem-
bers based on sequence or structural features include the
Frizzled and Smo receptors as related to the GPCR secretin
family [73–76]. Both Frizzled and Smo receptors display low
but significant sequence similarity to other GPRCs of the
secretin family particularly in their transmembrane domains
[77,78]. The alignment of representative members of the Fz,
secretin and Smo receptors is presented in Fig. 2. The Smo
protein has a long extra-cellular N-terminal domain about 250
amino acids long, and presents a conserved cystein-rich
domain (CRD). The cysteines in this domain are predicted to
be essential for acquiring the correct tertiary structure. In the
Smo-related Fz receptor, the CRD binds its ligand, the Wnt
protein [79]. Although the CDR of Smo binds neither Wnt nor
Hh protein [80], its evolutionary conservation suggests that it
may have an important role in Smo regulation, which has yet
to be determined. Interestingly, the missense mutation
Cys90Ser, localised in the CRD of the extra-cellular domain
of Drosophila Smo, is associated with a weak Smo loss of
function phenotype [50], suggesting that the occurrence of
correct disulphide bridges within the CRD are needed for Smo
activity. The CRD domain may also be required for the
interaction between Smo and Ptc. In this sense, some reports
have shown a weak interaction between PTC and the CRD of
Smo, and both proteins can be co-inmunoprecipitated when
over-expressed [81]. Direct interactions between Smo and Ptc,
however, have not been detected under physiological condi-
tions [82], probably reflecting that this interaction is weak and
transient. In addition, Ptc and Smo show minimal co-
localisation within the cell, and their interaction is not
stechiometric, as Ptc is able to inhibit excess of Smo
[46,50,82,83]. Other motifs of homology with the Secretin
family shared by Smo and Fz are located between the
transmembrane regions of these proteins.
3.2. Seven-transmembrane receptors dimerization
GPCRs have traditionally been thought to act as monomers,
but now is widely accepted that GPCRs may exist as either
homodimers or even higher-order oligomers.
They are also capable of interacting with distantly related
receptor subtypes to form hetero-oligomers and, for many
Fig. 2. Alignment of Smo receptors from representative vertebrate and invertebrate orthologs with other members of the secretin/frizzled GPCR family. The putative
regions comprising the transmembrane domains are noted in the alignment, as well as the cysteine-rich domain (CRD). The phosphoserine/threonine residues
identified in endogenous Drosophila Smo after Hh stimulation [99] are indicated by asterisks. Those phospho-residues that could be phosphorylated by GRKs family
members and are present in both Drosophila and human Smo protein are boxed. Amino acid sequences accession numbers are: Human-Smoothened (gi52032099),
Drosophila-Smoothened (gi27919934), human-Frizzled-2 (gi736679) and Human-secretin receptor (gi38609719).
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basic signalling unit during their normal intracellular traffick-
ing and function (reviewed in [84–86]. Certain GPCRs seem
to have a strict requirement for heterodimerization to attain
proper surface expression and functional activity such as the
GABAB receptor [87]. Heterodimerization can also lead to
marked changes in receptor pharmacology, signalling, and/or
internalisation.
There is not direct data demonstrating Smo dimerization, but
several observations concerning Smo and the related Frizzled
(Fz) receptors suggest that they also operate as dimers or
multimers. Thus, ectopic expression of Smo variants with C-
terminal deletions cause dominant-negative effects, and
increased expression of full-length Smo results in ectopic
activation of the pathway [88]. More recently, it has been
hypothesized that the highest level of Smo activity might
involve Smo dimerization [89]. Smo dimers would interact with
Cos2–Fu–Ci–Su(fu) complexes, activating Su(fu) phosphor-
ylation by Fu, and releasing the inhibition on Ci.3.3. Coupling of Smo to heterotrimeric G-proteins
There are emerging evidences pointing to a role of
heterotrimeric G-proteins as Smo effectors in vertebrates.
First, Smo is constitutively active in the absence of Ptc, and
the third intracellular loop and the seventh transmembrane
region of Smo are required for this function [90]. Both domains
are very important in other GPCRs for coupling with hetero-
trimeric G-proteins. Assays made in frog melonophores
expressing human Smo showed a phenotype of persistent
pigment aggregation, and this effect can be blocked by pertussis
toxin [91], a treatment known to ADP-ribosylate a cysteine
residue near the carboxyl terminus of Gαi or Gαo, disrupting
receptor-G protein coupling [92]. These results suggest that Smo
can signal through heterotrimeric G-proteins. In fact, it has been
recently shown that Smo activates all members of the Gαi
family, and this effect is an essential component of Gli activation
in mammalian fibroblasts [93]. In the same line, injection of
Zebrafish embryos with RNA encoding pertussis toxin and
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for it in Smo signalling [94]. Further support for a role of
heterotrimeric G proteins in Smo signal transduction is the
reported transcriptional stimulation of a Gli1 promoter in
HEK293 and N2a cells over-expressing constitutively active
Gα [95]. These data reveal that the Gα12/13/RhoA/RhoA kinase
pathway participates in Smo signalling. Indirect support for the
involvement of RhoA in Smo signalling is provided by the
analysis of moesinmutants in Drosophila.Moesin, encoding the
only member inDrosophila of the Radixin/Ezrin/Moesin family,
is required for correct epithelial development and its loss-of-
function alleles cause inappropriate Smo signalling. These
effects can be reverted by reducing the dose of the RhoA
GTPase [96].
Finally, several mutations in Smo that promote some
phenotypic features coincident with those of canonical
GPCRs provide additional support for Smo/G-protein coupling.
A somatic missense mutation in human Smo, caused by an
amino acid substitution in the seventh transmembrane domain
(Trp535Leu), a site predicted to disrupt G-protein coupling [97],
cause Smo activation. Similarly, a smo loss of function
phenotype can be generated by the K474C missense mutation
in Smo, which changes an Arg residue localised in the third
intracellular loop, close to the boundary with transmembrane
TM6. This mutation is similar to other found to abolish G-
protein coupling in other GPCRs [50], indicating an important
role for these domains in Smo function.
However other data suggest that G-proteins are not always
required for Smo signalling. In vitro studies using a primary fish
myoblast assay system reveal that the response to Shh is
insensitive to pertussis toxin treatment. Moreover, there is to
date no report of mutations in a Drosophila G-protein giving a
phenotype reminiscent of Smo signalling disruption [94], and
studies using RNA interference to inhibit a full spectrum of G-
protein subunits in Drosophila tissue culture cells failed to
compromise Hh signalling [8]. The observed coupling of Smo
to Gαi-proteins occurring in particular cell types could be part
of a mechanism used to reduce PKA activity by decreasing the
level of cAMP, preventing Gli phosphorylation and amplifying
Smo signalling. Additional inputs from Smo to Gli contributing
to pathway activation depend on the integrity of the C-terminal
domain of Smo and might be mediated by Smo phosphorylation
by GRK2 (see below). In addition, the effects on Smo signalling
caused by G protein activity modifications could be indirect,
based on changes on cytoskeleton architecture or vesicular
trafficking mediated by these proteins.
4. Smo phosphorylation
Drosophila Smo activation is accompanied by its phos-
phorylation, accumulation and translocation to the plasma
membrane [46,50,59,98–100]. When Hh is present, the Smo
C-terminal tail becomes hyper-phosphorylated by protein kinase
A (PKA) and Casein kinase I (CKI) (see Fig. 1B). Loss of these
PKA or CK1 sites, using un-phosphorylatable (Ser/Thr→A)
forms of Smo renders Smo inactive, whereas changes ofmultiple
serine residues to acidic residues (Ser/Thr→D mutants,phosphorylation-mimicking forms) activate signalling even in
the absence of Hh [98–100]. Zhang and collaborators [99]
identified 26 serine and threonine residues within the Droso-
phila Smo C-terminal cytoplasmic tail (marked with asterisks in
Fig. 2) that become phosphorylated upon Hh stimulation in S2
Drosophila cell lines. There are some identified phosphoserine
and phosphothreonine residues that lye in consensus kinase
recognition motifs for PKA, CKI and GSK3 among others, but
there are also phosphoresidues that do not belong to consensus
motifs for any of these kinases. Most of these Smo phosphory-
lated residues are not conserved in vertebrates, suggesting that
activation of vertebrate Smo is not triggered by PKA and CKI
phosphorylation. Thus, other kinases might play a role in
vertebrate Smo activation and, in fact, in vitro approaches using
mammalian cell culture models revealed that upon Hh stimula-
tion, Smo protein is phosphorylated by the G protein-coupled
receptor kinase GRK2 [101]. As it happens for other GPCRs,
phosphorylation of Smo by GRK2 promotes binding of β-
arrestin-2 and Smo internalisation (see below). This observation
suggests that different sets of kinases might be implicated in
regulating Smo activity in vertebrates and Drosophila.
Interestingly, a Drosophila Smo mutant with acidic residues
in place of PKA and CK1-targeted serine residues can be
further activated by Hh treatment, indicating that additional
changes in Smo can be induced by Hh, conceivably involving
additional phosphorylation sites [98–100]. Some of those
identified residues are in the vicinity of acidic residues that fit a
“GRKs phosphorylation consensus-sequence” observed in both
plasma membrane receptors and cytoplasmic substrates of
GRK2 [102–106]. Some of these phosphorylated residues are
present both in Drosophila and in vertebrate Smo C-terminal
cytoplasmatic tails (Ser 633, 634, 680, 746; Fig. 2 mark as
square) [99], suggesting that GRK phosphorylation of Smo
might be conserved in Drosophila and vertebrates.
5. Implication of the canonical GPRC signalling components
GRK and β-arrestin in Smo signalling
In the last 2 years a new connection has been established
between Smo signalling and some proteins involved in
canonical GPCR regulation and signalling: the cytosolic β-
arrestin proteins and the G protein-coupled receptor kinase
GRK [96,101,107]. Canonical GPCR stimulation promotes the
activation of heterotrimeric G proteins, and triggers receptor
phosphorylation in Ser/Thr residues by GRKs. β-arrestins then
bind to the phosphorylated receptor, leading to (i) impaired
communication of the receptor with the G protein even in the
presence of stimulus, (ii) induction of clathrin-mediated
receptor internalisation, mediating its coupling to the endocytic
machinery. Internalised receptors can then be dephosphorylated
by the action of specific phosphatases in low pH endosomes and
recycled to the plasma membrane (resensitization), or be
degraded in lysosomes [101,108–110]. In addition, binding of
β-arrestins can recruit additional proteins to the membrane,
acting as signal transducers through the formation of scaffold-
ing complexes with accessory effector molecules such as Src,
Raf, ERK1/2, JNK3, MAPK4 and p38 [111–116].
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protein activity and localisation is not exclusive to GPCRs. For
example, the non-visual arrestin of Drosophila encoded by
Kurtz interacts with the putative E3 ubiquitin ligase Deltex, and
promotes ubiquitination and degradation of the Notch receptor
[117]. Arrestin also constitutes an essential component in the
signalling pathways initiated by the insulin-like growth factor 1
(IGF-1) by promoting ubiquitination of the receptor by the E3
ubiquitin ligase oncoprotein MDM2 [116]. β-arrestin2 can also
bind to the single transmembrane-spanning type II TGFβ
receptor, and its binding is triggered by receptor auto-
phosphorylation [101,105].
In addition to arrestin, GRK proteins have also been involved
in the modulation of both non-GPCR receptors and other non-
receptor proteins. Thus, GRKs are able to phosphorylate non-
receptor substrates such as tubulin, synucleins, phosducin,
ribosomal protein P2, the inhibitory γ-subunit of the type 6
retinal cGMP phosphoriesterase, a subunit of the epithelial Na+-
channel and ezrin [68,102,105,106,118–121]. GRKs also
participate in several pathways and modulate cellular functions
in a phosphorylation-independent manner. These actions of
GRKs are due to their ability to interact with a variety of
proteins involved in signalling and trafficking, such as Gαq,
Gβγ, caveolin, or GIT [122–124]. Finally, arrestins and GRKs
also participate in several signalling platforms regulating other
receptor families, such as tyrosine kinase receptors [125,126].
The secretin receptor, belonging to the same family of GPCR
as Smo and Fz, can be phosphorylated by GRK2 and GRK5
upon binding of agonists, promoting its desensitization [127].
Secretin is not the only member of this family that becomes
phosphorylated by GRKs upon agonist stimulation. Smo over-
expression in mammalian cultured cells recruits β-arrestin2 to
the plasma membrane [101]. A regulatory role for β-arrestin 2
in the Hh signalling pathway has also been described in vivo.Fig. 3. Putative roles of β-arrestin and GRK2/Gprk2 in Smo regulation. Smo receptor
is released and rapidly phosphorylated by a G-protein coupled receptor kinase
internalisation. Once internalised, Ptc is degraded and Smo can be recycled back to the
β-arrestin would be released, so Smo can be further phosphorylated by other kinase
active form to the plasma membrane.Thus, functional knockdown of β-arrestin 2 by morpholino
depletion in zebrafish embryos lead to phenotypes similar to
those resulting from mutants in the Hh pathway, indicating a
functional interaction between β-arrestin2 and Smo [107]. This
interaction was demonstrated in mammalian cell culture
experiments, which showed that both β-arrestin and GRK2
mediate clathrin-dependent internalisation of active Smo.
Furthermore, Ptc, as well as the antagonist cyclopamine,
inhibits the association of β-arrestin 2 with Smo, and this
inhibition is relieved in cells treated with the agonist Shh [101].
Finally, a direct requirement of mammalian GRK2 in Smo
signalling has been identified in C3H10TI/2 cells, where GRK2
promotes coupling of β-arrestin and Smo [128]. Because the
integrity of the Smo C-terminal, in addition to G-protein
coupling, is necessary for Gli activation [93], it is tempting to
speculate that GRK2 activity acting through the Smo C-terminal
domain is a key component of Smo pathway activation.
The vertebrate β-arrestins and GRK proteins have homo-
logous genes in Drosophila, although their functional char-
acterisation has not yet being reported for most of them. There
are two GRKs in Drosophila, GPRK1 and GPRK2, which share
homology with members of the mammalian subfamilies 2 and
4, respectively. GPRK1 (more similar in sequence to mamma-
lian GRK2 and GRK3) modulates the amplitude of the visual
response acting as a Rhodopsin kinase [129]. GPRK2 has
higher sequence identity with mammalian members of the
GRK4 subfamily (GRK4–6), and its function is required to
regulate the level of cAMP during Drosophila oogenesis
[130,131]. Recent work in our laboratory using the Drosophila
model revealed that when Grpk2 levels are lowered the function
of Smo is impaired. Thus, flies expressing interference RNA
directed against GPRK2 display a phenotype similar to that
characteristic of Smo loss-of-function alleles [132]. Further-
more, loss of GPRK2 also affects Smo protein localisation andactivity is constitutively inhibited by Ptc. Upon Hh binding to Ptc receptor, Smo
(GRK) family member, thus leading to β-arrestin recruitment, and receptor
plasma membrane. It is tentatively speculated that in the endocytic compartment
s such as PKA and CKI. As a final step, Smo receptor would be recycled in an
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activation of Smo [132]. So far, no Drosophila β-arrestin
homolog has been reported to affect Hh signalling. In this
regard, in vivo studies in vertebrates also have shown that β-
arrestin 2 acts as a positive regulator of the Hh pathway in
zebrafish [107]. However, there are no data concerning the role
of β-arrestin and GRKs during mammalian development. Mice
lacking either β-arrestin 1 or β-arrestin 2 are viable, whereas
those lacking both are embryonic lethal [133], although the
double-mutant embryos have to our knowledge not been
examined for defects in Hh signalling. Mice lacking Grk2 die
between embryonic day (E) 9.0 and E15.5 with heart
abnormalities [134], but again analysis of a potential Hh/Smo
signalling-related phenotype has not been reported.
In sum, these results suggest that Smo regulation by GRK
family members and subsequent β-arrestin protein interaction
are important in the Hh pathway, both in vertebrates and
invertebrates, probably involving modulation of Smo phos-
phorylation, stability and subcellular localisation (see proposed
model in Fig. 3). Further research in both cellular and animal
models will help to understand the mechanisms involved in the
functional interaction among GRKs, β-arrestins and compo-
nents of Smo signalling pathway, and its physiological and
pathological implications.References
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